Investment Rating - The report maintains a "Buy" rating for Tencent Holdings [7][48]. Core Insights - The report highlights solid revenue growth driven by AI investments, with Tencent expected to leverage its position as the largest social media platform to enhance its value through AI [3][48]. - For FY25 Q4, Tencent reported revenue of RMB 194.4 billion, a year-on-year increase of 12.7%, and an adjusted net profit of RMB 64.7 billion, up 17.0% year-on-year [48]. - The report projects Tencent's revenue for 2026-2028 to be RMB 830.2 billion, RMB 901.3 billion, and RMB 974.4 billion, respectively, with adjusted net profits of RMB 277.2 billion, RMB 303.4 billion, and RMB 333.4 billion [48]. Financial Summary - **Revenue Forecast (in million RMB)**: - 2024A: 660,257 - 2025A: 751,766 - 2026E: 830,224 - 2027E: 901,271 - 2028E: 974,440 - Year-on-year growth rates: 8.4%, 13.9%, 10.4%, 8.6%, 8.1% [5]. - **Adjusted Net Profit Forecast (in million RMB)**: - 2024A: 222,703 - 2025A: 259,626 - 2026E: 277,153 - 2027E: 303,380 - 2028E: 333,417 - Year-on-year growth rates: 41.2%, 16.6%, 6.8%, 9.5%, 9.9% [5]. - **Adjusted Net Profit Margin**: - 2024A: 33.7% - 2025A: 34.5% - 2026E: 33.4% - 2027E: 33.7% - 2028E: 34.2% [5]. Segment Performance - **Value-Added Services**: Revenue reached RMB 899 billion in FY25 Q4, a 13.8% increase year-on-year, with domestic and overseas game revenues growing by 15.1% and 31.9%, respectively [48]. - **Marketing Services**: Revenue of RMB 411 billion in FY25 Q4, up 17.5% year-on-year, driven by AI-enhanced advertising capabilities [48]. - **Financial Technology and Enterprise Services**: Revenue increased by 8.4% year-on-year, supported by growth in cloud services and WeChat store transactions [48]. Operational Data - The integration of AI into Tencent's social ecosystem is expected to drive healthy growth, with WeChat's monthly active users (MAU) showing a slight increase of 0.3% [41][42]. - The report notes a significant increase in R&D spending, which reached RMB 238 billion in FY25 Q4, reflecting a 20% year-on-year increase [19][48].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][10] Core Insights - The company achieved a total delivery volume of 597,000 vehicles in 2025, representing a year-on-year increase of 103.1%. The total revenue reached 64.73 billion yuan, up 101.3% year-on-year, and the net profit was 540 million yuan, marking the first annual profit. The annual gross margin was 14.5%, with a record high of 15.0% in Q4 2025 [5][6]. Financial Performance - In Q4 2025, the company delivered 201,000 vehicles, a year-on-year increase of 66.3% and a quarter-on-quarter increase of 15.6%. The quarterly revenue was 21.03 billion yuan, up 56.3% year-on-year and 8.1% quarter-on-quarter. The quarterly net profit was 360 million yuan, reflecting a year-on-year increase of 350.0% and a quarter-on-quarter increase of 140.0% [6]. - The company forecasts revenues of 108.67 billion yuan, 141.98 billion yuan, and 171.80 billion yuan for 2026, 2027, and 2028, respectively, with year-on-year growth rates of 68%, 31%, and 21% [9][10]. Product Launches and Market Expansion - The company plans to launch four new models in 2026: A10, D19, D99, and A05. The A10 is positioned as a global smart long-range SUV, set to launch on March 26, 2026, with a pure electric range of 403-505 km. The D19 is a "tech luxury flagship SUV" targeting the 300,000 yuan full-size SUV market. The D99, the company's first MPV, will offer both range-extended and pure electric options, focusing on family users. The A05 is a compact electric vehicle expected to launch in June-July 2026 [6]. - The company aims for overseas sales of 100,000 to 150,000 vehicles in 2026, with approximately 900 sales service outlets established in about 40 international markets by the end of 2025. The company has entered the South American market, launching models C10 and B10 in Brazil [6]. Management Confidence - The management's confidence in the company's future is reflected in their stock purchases, indicating a positive outlook on the company's growth trajectory [7].

Investment Rating - The investment rating for the company is "Outperform the Market" [6][4]. Core Insights - The company's short-term performance is impacted by public sentiment events and intensified industry competition, with projected revenue for 2025 at 55.19 billion, a year-on-year decrease of 0.4%, and adjusted net profit at 19.60 billion, down 8.9% year-on-year [2][4]. - The company anticipates a revenue growth rate of approximately 10% for 2026, with a slight decline in gross margin due to changes in product mix and rising raw material costs [2][4]. - The brand "可复美" generated revenue of 44.70 billion, a decrease of 1.6% year-on-year, while "可丽金" achieved revenue of 9.18 billion, an increase of 9.2% year-on-year, benefiting from online channel expansion and successful product upgrades [2][4]. Financial Performance Summary - Revenue from direct sales channels was 41.35 billion, remaining stable year-on-year, accounting for 74.9% of total revenue, while distribution channel revenue was 13.83 billion, down 1.5% year-on-year [3]. - The gross margin for 2025 is projected at 80.3%, down 1.8 percentage points year-on-year, with a net profit margin of 34.7%, down 2.5 percentage points year-on-year [3]. - The company plans to launch multiple skincare products in 2026, aiming to revitalize the performance of its functional skincare segment [4]. Earnings Forecast and Financial Metrics - The earnings forecast for 2025 includes revenue of 55.19 billion and net profit of 19.60 billion, with projections for 2026 and 2027 showing revenue growth of 9.6% and 7.3%, respectively [5][18]. - The projected PE ratios for 2026, 2027, and 2028 are 16, 15, and 14 times, respectively, reflecting adjustments due to public sentiment impacts and increased brand investment [4][5].

Investment Rating - The report assigns a "Buy" rating, expecting a price increase of over 15% within the next 6-12 months [12] Core Insights - The company reported a net profit of 1.102 billion yuan for 2025, a year-on-year increase of 82.5%, with adjusted net profit reaching 1.8 billion yuan, reflecting a remarkable growth of 198.3% [2] - The improvement in underwriting and investment performance, along with profitability in both banking and technology sectors, contributed to the high elasticity of profit growth [2] - The insurance business showed strong performance with a premium growth of 6.9% and a combined ratio (COR) improvement to 95.8% [3] - The virtual bank, ZA Bank, achieved its first annual profit, with retail users exceeding 1 million and net income growing by 62.7% to 892 million HKD [4] Summary by Sections Financial Performance - The company's total investment income increased by 59.1% to 2.12 billion yuan, driven by the recovery in equity markets [2] - The insurance business's net profit for 2025 was 1.68 billion yuan, while technology and banking segments reported net profits of 50 million yuan and 10 million yuan, respectively [2] - The combined ratio (COR) for the insurance business improved to 95.8%, with a loss ratio of 57.1% and an expense ratio of 38.7% [3] Business Segments - Health insurance premiums grew by 22.7%, with a significant contribution from AI-enhanced marketing efficiency [3] - The digital lifestyle segment saw a slight decline in total premiums by 1.4%, but innovative business premiums surged by 37.2% [3] - The automotive insurance segment experienced a robust growth of 34.6%, particularly in new energy vehicle insurance, which grew by approximately 206.2% [3] - The consumer finance segment faced a decline in premiums by 10.6%, prompting the company to reduce scale to manage risks [3] Valuation and Forecast - The company's fundamentals show significant improvement, with expectations for continued premium growth in the insurance sector driven by health, auto, and innovative business lines [5] - The projected price-to-book (PB) ratio for 2026 is 0.79, indicating a historically low valuation [5]

Investment Rating - The report maintains a "Buy" rating for the company, with a current price of HKD 30.70 and a fair value estimate of HKD 33.66 [4][9]. Core Insights - The company's performance is under short-term pressure, but there is optimism regarding the long-term value of its collagen products due to ongoing restructuring efforts [1][9]. - In 2025, the company reported revenue of RMB 55.2 billion, a slight decline of 0.4% year-on-year, and a net profit of RMB 19.1 billion, down 7.2% year-on-year [9][10]. - The report highlights a competitive industry landscape and changes in product structure that have led to a decrease in gross margin by 1.8 percentage points to 80.3% [9][10]. Financial Projections - Revenue is projected to grow from RMB 6.07 billion in 2026 to RMB 7.89 billion in 2028, with growth rates of 10.0%, 13.1%, and 14.9% respectively [2][10]. - The net profit is expected to increase from RMB 19.8 billion in 2026 to RMB 23.9 billion in 2028, with growth rates of 4%, 9%, and 11% respectively [10][11]. - The report anticipates a decline in overall gross margin to around 78%-79% during 2026-2028 due to a shift in product mix [10][11]. Business Segment Analysis - The efficacy skincare segment generated revenue of RMB 43.4 billion in 2025, showing a slight increase of 0.8% year-on-year, driven by enhanced marketing efforts [9][10]. - The medical beauty dressing segment saw revenue of RMB 11.6 billion, down 4.8% year-on-year, primarily due to price maintenance and channel sales control [9][10]. - Brand performance varied, with "可复美" (Kefumei) revenue declining by 1.6% to RMB 44.7 billion, while "可丽金" (Kelin) revenue increased by 9.2% to RMB 9.2 billion, benefiting from online channel expansion [9][10]. Channel Performance - Online direct-to-consumer (DTC) sales reached RMB 34.0 billion, down 5%, while e-commerce platform direct sales increased by 35% to RMB 5.1 billion [9][10]. - Offline direct sales grew by 32% to RMB 2.2 billion, supported by an increase in the number of cosmetic chain stores [9][10]. - Revenue from distributors decreased by 2% to RMB 13.8 billion due to pricing and channel management pressures [9][10]. Investment Recommendations - The company is in a critical phase of product matrix upgrade and channel structure optimization, with short-term performance adjustments expected to be absorbed [10][11]. - The report suggests that with the launch of new medical beauty products and improved online channel efficiency, the company is likely to return to a growth trajectory by 2026 [10][11].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a total revenue of USD 2.619 billion for 2025, reflecting a year-over-year increase of 2%. The core net profit after tax reached USD 746 million, marking an 18% increase year-over-year, excluding non-recurring items. This represents a historical high for the company. The dividend per share was USD 0.4537, corresponding to a dividend payout ratio of 40%, which is also a record high for comparable historical data. The dividend yield based on the closing price on March 19 was 4.63% [4][6]. Financial Data and Earnings Forecast - The company is projected to achieve total revenues of USD 2.772 billion in 2026, with a year-over-year growth rate of 5.8%. The net profit attributable to shareholders is expected to be USD 839 million, reflecting a 6.6% increase year-over-year. The earnings per share (EPS) is forecasted to be USD 1.21, with a return on equity (ROE) of 11.8% [5][7]. - The company’s operating income is expected to grow steadily, with total revenues projected to reach USD 3.096 billion by 2028, indicating a compound annual growth rate (CAGR) of approximately 7.2% from 2025 to 2028 [5][7]. Revenue Breakdown - The revenue from aircraft leasing remains stable at over 70%, while revenue from aircraft sales increased by over 80% year-over-year. In 2025, leasing income was USD 1.89 billion (up 2% year-over-year), aircraft sales generated USD 213 million (up 81% year-over-year), and interest and fees amounted to USD 516 million (down 12% year-over-year) [6]. Asset Management - The company’s fleet expanded to 815 aircraft by the end of 2025, up from 709 at the end of 2024. The average age of the fleet remains at 5.0 years, with an average remaining lease term of 7.8 years, which is the longest among peers. The company plans to purchase 160 new aircraft, expanding its order book to 337 aircraft [6]. Profitability and Cost Management - The average valuation of aircraft increased by 18% compared to book value, leading to higher lease rates. The net leasing yield is expected to rise to 7.5% in 2025, up from 7.2% in 2024. Operating costs for aircraft decreased by 3% year-over-year, while financial costs remained stable at 4.5% [6].

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company has reported its 2025 annual performance, achieving revenue of 5.519 billion yuan, a year-on-year decrease of 0.4%, and a net profit attributable to shareholders of 1.915 billion yuan, down 7.2% year-on-year [2] - The company plans to distribute a total dividend of 1.2104 yuan per share, amounting to approximately 1.29 billion yuan [2] - The company is expected to return to a growth trend in 2026, driven by new product launches and improved channel structures [8] Revenue Summary - In 2025, the company's revenue was 5.519 billion yuan, with a breakdown by product category showing functional skincare products at 4.337 billion yuan (+0.8% YoY), medical dressings at 1.16 billion yuan (-4.8% YoY), and health food and others at 0.22 billion yuan (+17.9% YoY) [3] - By brand, revenue from Kefu Mei was 4.47 billion yuan (-1.6% YoY), Keli Jin at 0.918 billion yuan (+9.2% YoY), and others at 0.22 billion yuan (+17.9% YoY) [3] - Revenue by channel showed DTC online sales at 3.402 billion yuan (-5.2% YoY), e-commerce platform sales at 0.509 billion yuan (+34.8% YoY), offline sales at 0.225 billion yuan (+32.3% YoY), and distribution at 1.383 billion yuan (-1.5% YoY) [3] Profitability Summary - The company's gross margin for 2025 was 80.34%, a decrease of 1.76 percentage points year-on-year, with a net profit margin of 34.70%, down 2.52 percentage points year-on-year [4] - The company’s operating expenses ratio for 2025 was 41.92%, an increase of 1.02 percentage points year-on-year, with significant increases in sales expenses [5] Product and Channel Development - The company is focusing on product development and channel construction to drive high-quality brand growth, with plans to launch new products and expand into new markets [6][7] - The company is enhancing its online operations and expanding its offline store presence, including entry into overseas markets such as Singapore and Malaysia [7] Financial Forecast - The company forecasts revenues of 6.113 billion yuan, 6.932 billion yuan, and 7.821 billion yuan for 2026, 2027, and 2028 respectively, with net profits of 1.950 billion yuan, 2.139 billion yuan, and 2.334 billion yuan for the same years [8][10] - The expected earnings per share (EPS) for 2026, 2027, and 2028 are 1.82 yuan, 2.00 yuan, and 2.18 yuan respectively, with corresponding price-to-earnings (PE) ratios of 16, 14, and 13 [8][10]

Investment Rating - The report maintains a "Buy" rating for Tencent Holdings [7][48]. Core Insights - The report highlights solid revenue growth driven by AI investments, with Tencent expected to achieve revenues of 830.2 billion, 901.3 billion, and 974.4 billion RMB for the years 2026 to 2028, respectively. Adjusted net profits are projected to be 277.2 billion, 303.4 billion, and 333.4 billion RMB for the same years [48]. - The fourth quarter of FY25 saw Tencent's revenue reach 194.4 billion RMB, a year-on-year increase of 12.7%, with adjusted net profit rising by 17.0% to 64.7 billion RMB [48]. - The report emphasizes the integration of AI into Tencent's advertising technology and social ecosystem, enhancing user engagement and driving revenue growth across various segments [3][41]. Financial Summary - **Revenue Forecasts (Million RMB)**: - 2024A: 660,257 - 2025A: 751,766 - 2026E: 830,224 - 2027E: 901,271 - 2028E: 974,440 - Revenue growth rates are projected at 8.4%, 13.9%, 10.4%, 8.6%, and 8.1% respectively [5]. - **Adjusted Net Profit Forecasts (Million RMB)**: - 2024A: 222,703 - 2025A: 259,626 - 2026E: 277,153 - 2027E: 303,380 - 2028E: 333,417 - Adjusted net profit growth rates are 41.2%, 16.6%, 6.8%, 9.5%, and 9.9% respectively [5]. - **Adjusted Net Profit Margin**: - 2024A: 33.7% - 2025A: 34.5% - 2026E: 33.4% - 2027E: 33.7% - 2028E: 34.2% [5]. Segment Performance - **Value-Added Services**: Revenue increased by 13.8% year-on-year to 899 billion RMB in Q4, with domestic and overseas game revenues growing by 15.1% and 31.9%, respectively [28][36]. - **Marketing Services**: Revenue rose by 17.5% year-on-year to 411 billion RMB, benefiting from AI-driven advertising capabilities [32]. - **Financial Technology and Enterprise Services**: Revenue grew by 8.4% year-on-year, driven by increased cloud service revenues and expanded transaction volumes in WeChat stores [39]. Operational Data - The report notes that WeChat's monthly active users (MAU) increased by 0.3% in Q4, while QQ's mobile MAU decreased by 1.7% [42]. - The number of paid users for value-added services increased by 0.8% quarter-on-quarter [46]. Earnings Forecast and Investment Advice - The report suggests that Tencent, as the largest social media traffic entry point, is well-positioned to leverage AI to reconstruct platform value. The estimated reasonable valuation for the stock is 621 HKD per share based on an 18x PE ratio for 2026 [48][49].

Investment Rating - The report maintains a "Cautious Recommendation" rating for Huazhu Group [2] Core Insights - The company reported a revenue of 6.5 billion RMB in Q4 2025, representing an 8.3% year-on-year increase, exceeding the upper limit of guidance [8] - Adjusted EBITDA for Q4 2025 was 2.19 billion RMB, a significant increase of 76.1% year-on-year [8] - The net profit attributable to shareholders for Q4 2025 reached 1.2 billion RMB, marking a substantial year-on-year growth [8] - The RevPAR for Legacy-Huazhu in Q4 2025 was 226 RMB, reflecting a 2.0% year-on-year increase, with ADR up by 4.1% [8] - The company opened 406 new hotels in Q4 2025, contributing to a total of 2,444 new hotels for the year, a historical high [8] - The company plans to open approximately 2,200 to 2,300 new hotels in 2026, supported by a reserve of 2,887 hotels [8] Financial Forecasts - Revenue projections for 2026, 2027, and 2028 are 26.623 billion RMB, 28.167 billion RMB, and 29.773 billion RMB, respectively, with growth rates of 5.2%, 5.8%, and 5.7% [2] - Net profit attributable to shareholders is expected to be 5.372 billion RMB, 5.775 billion RMB, and 6.348 billion RMB for 2026, 2027, and 2028, with growth rates of 5.7%, 7.5%, and 9.9% [2] - Earnings per share (EPS) are projected to be 1.73 RMB, 1.86 RMB, and 2.04 RMB for the same years [2] - The current price corresponds to a PE ratio of 21, 19, and 17 for the years 2026, 2027, and 2028, respectively [2]

Investment Rating - The investment rating for the company is "Buy" [7] Core Insights - The company's revenue and profit margins are under pressure for 2025, primarily due to public sentiment and broadcasting impacts. The company has multiple new cosmetic products in the pipeline and has received approval for two medical beauty injectables, which are key areas to monitor for future performance [2][11]. Financial Summary - Total revenue for 2025 is projected at 5,519 million RMB, a slight decrease of 0.4% year-on-year. Net profit is expected to be 1,915 million RMB, down 7% year-on-year. The gross profit margin for 2025 is estimated at 80.34%, a decrease of 1.76 percentage points compared to the previous year [4][11]. - The company anticipates a revenue increase to 6,064 million RMB in 2026, with a projected net profit of 1,914 million RMB, remaining stable year-on-year [4][11]. - The company's PE ratio is expected to decrease from 22.89 in 2024 to 17.12 in 2025, indicating a more attractive valuation over time [4][11]. Brand and Product Development - The main brand, Kefu Mei, is experiencing a slight decline due to public sentiment and broadcasting efficiency issues. In 2025, Kefu Mei's revenue is expected to be 4,470 million RMB, a decrease of 2% year-on-year, while the Keli Jin brand is projected to grow by 9% to 917 million RMB [11]. - The company is focusing on enhancing its medical beauty business, with new products expected to launch in 2026, including collagen repair series and other functional skincare products [11].